KIMIA BIOSCIENCES
Back to Balance Sheet
|
KIMIA BIOSCIENCES Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹18 Cr | ₹24 Cr | ₹35 Cr | ₹32 Cr | ₹37 Cr |
What is the latest Total Non-Current Liabilities ratio of KIMIA BIOSCIENCES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹18 Cr |
| Mar2024 | ₹24 Cr |
| Mar2023 | ₹35 Cr |
| Mar2022 | ₹32 Cr |
| Mar2021 | ₹37 Cr |
How is Total Non-Current Liabilities of KIMIA BIOSCIENCES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹18 Cr | -27.67 | |
| Mar2024 | ₹24 Cr | -31.20 | |
| Mar2023 | ₹35 Cr | 11.27 | |
| Mar2022 | ₹32 Cr | -14.46 | |
| Mar2021 | ₹37 Cr | - | |
Compare Total Non-Current Liabilities of peers of KIMIA BIOSCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KIMIA BIOSCIENCES | ₹138.4 Cr | -0.3% | -3.6% | -24.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,634.0 Cr | -2.9% | -2.3% | 21.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹241,576.0 Cr | -1.6% | 9.8% | 51.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.6% | -2.3% | 37.5% | Stock Analytics | |
| CIPLA | ₹111,888.0 Cr | -2.2% | -6.1% | -12.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,322.1 Cr | -0.9% | -1.8% | -9.8% | Stock Analytics | |
KIMIA BIOSCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KIMIA BIOSCIENCES | -0.3% |
-3.6% |
-24.8% |
| SENSEX | -1% |
-2.6% |
-4.1% |
You may also like the below Video Courses